from

ASTRAUX Redefines Urban Mobility: SEV Shocks Europe Market from Just 5,999

BERLIN, Sept. 5, 2025 /PRNewswire/ --  ASTRAUX, a Dubai-based global lifestyle tech brand, is redefining the future of urban mobility. At…

3 weeks ago

With Demand From 171 Countries, iMeUsWe Launches Personalised Astrology Services

PUNE, India, Sept. 4, 2025 /PRNewswire/ --  iMeUsWe, India's leading family platform, is taking a big step forward by launching…

3 weeks ago

Supersonik gets $5M from Andreessen Horowitz for its AI agent that runs live product demos

San Francisco, Sept. 04, 2025 (GLOBE NEWSWIRE) -- In a world where buyers expect everything on demand, sales teams are…

3 weeks ago

TBO TO ACQUIRE CLASSIC VACATIONS FROM THE NAJAFI COMPANIES TO EXPAND ITS GLOBAL REACH INTO NORTH AMERICA

TBO's purchase of the leading U.S. luxury travel wholesaler elevates its premium outbound travel market services across the global stage…

3 weeks ago

From 50,000 to 700,000 SKUs: Speed Parts Drives 20%+ Annual Growth with Maropost

SUNSHINE COAST, Australia, Sept. 2, 2025 /PRNewswire/ -- Speed Parts, one of Australia's top automotive parts retailers, has turbocharged its…

3 weeks ago

Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL

 – establishing U.S. manufacturing footprint – BASEL, Switzerland, Sept. 2, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality, sustainable…

3 weeks ago

Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory…

3 weeks ago

Wonderful Indonesia Shines at ITB India 2025: From Bali to Beyond

MUMBAI, India , Aug. 30, 2025 /PRNewswire/ -- Indonesia is set to make a strong statement at ITB India 2025, bringing the…

4 weeks ago

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to…

4 weeks ago

Arclin Enters into Definitive Agreement to Acquire Aramids Business, including Kevlar and Nomex Brands, from DuPont

Acquired brands to broaden and complement Arclin's innovation platform ALPHARETTA, Ga., Aug. 29, 2025 /PRNewswire/ -- Arclin announced today it has…

4 weeks ago